Using the survival analysis, we found that CCNE1, NPBWR1, A2ML1 and TTK might act critical functions in the oncogenesis and progression of BRCA1/2-mutant breast cancer, reflected by their diagnostic efficacy for BRCA1/2 mutations and prognostic value as well. The gene discussed is TTK; the disease is breast carcinoma.